Abstract
Lin28b is an RNA-binding protein that inhibits biogenesis of let-7 microRNAs. LIN28B is overexpressed in diverse cancers, yet a specific role in the molecular pathogenesis of colon cancer has to be elucidated. We have determined that human colon tumors exhibit decreased levels of mature let-7 isoforms and increased expression of LIN28B. To determine LIN28B's mechanistic role in colon cancer, we expressed LIN28B in immortalized colonic epithelial cells and human colon cancer cell lines. We found that LIN28B promotes cell migration, invasion and transforms immortalized colonic epithelial cells. In addition, constitutive LIN28B expression increases expression of intestinal stem cell markers LGR5 and PROM1 in the presence of let-7 restoration. This may occur as a result of Lin28b protein binding LGR5 and PROM1 mRNA, suggesting that a subset of LIN28B functions is independent of its ability to repress let-7. Our findings establish a new role for LIN28B in human colon cancer pathogenesis, and suggest LIN28B post-transcriptionally regulates LGR5 and PROM1 through a let-7-independent mechanism.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akao Y, Nakagawa Y, Naoe T . (2006). let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29: 903–906.
Balzer E, Heine C, Jiang Q, Lee VM, Moss EG . (2010). LIN28 alters cell fate succession and acts independently of the let-7 microRNA during neurogliogenesis in vitro. Development 137: 891–900.
Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M et al. (2007). Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449: 1003–1007.
Boyerinas B, Park SM, Shomron N, Hedegaard MM, Vinther J, Andersen JS et al. (2008). Identification of let-7-regulated oncofetal genes. Cancer Res 68: 2587–2591.
Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, Dews M et al. (2009). Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci USA 106: 3384–3389.
Clevers H . (2006). Wnt/beta-catenin signaling in development and disease. Cell 127: 469–480.
Erisman MD, Rothberg PG, Diehl RE, Morse CC, Spandorfer JM, Astrin SM . (1985). Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Mol Cell Biol 5: 1969–1976.
Esquela-Kerscher A, Slack FJ . (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259–269.
Flint N, Cove FL, Evans G . (1991). A low-temperature method for the isolation of small intestinal epithelium along the crypt-villus axis. Biochem J 280: 331–334.
Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N et al. (2004). The Microprocessor complex mediates the genesis of microRNAs. Nature 432: 235–240.
Guo Y, Chen Y, Ito H, Watanabe A, Ge X, Kodama T et al. (2006). Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene 384: 51–61.
Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P et al. (2010). PAR-CliP--a method to identify transcriptome-wide the binding sites of RNA binding proteins. J Vis Exp 41 (doi:10.3791/2034).
Hagan JP, Piskounova E, Gregory RI . (2009). Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nat Struct Mol Biol 16: 1021–1025.
Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN . (2004). The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 18: 3016–3027.
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. (1998). Identification of c-MYC as a target of the APC pathway. Science 281: 1509–1512.
Heo I, Joo C, Cho J, Ha M, Han J, Kim VN . (2008). Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell 32: 276–284.
Heo I, Joo C, Kim YK, Ha M, Yoon MJ, Cho J et al. (2009). TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell 138: 696–708.
Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D et al. (2007). The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67: 7713–7722.
Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. (2005). RAS is regulated by the let-7 microRNA family. Cell 120: 635–647.
Keene JD, Komisarow JM, Friedersdorf MB . (2006). RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts. Nat Protoc 1: 302–307.
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J et al. (2003). The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415–419.
Lee Y, Jeon K, Lee JT, Kim S, Kim VN . (2002). MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21: 4663–4670.
Lee YS, Dutta A . (2007). The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21: 1025–1030.
Mayr C, Hemann MT, Bartel DP . (2007). Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315: 1576–1579.
Moss EG, Tang L . (2003). Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites. Dev Biol 258: 432–442.
Park SM, Shell S, Radjabi AR, Schickel R, Feig C, Boyerinas B et al. (2007). Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6: 2585–2590.
Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B et al. (2000). Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408: 86–89.
Pino MS, Chung DC . (2010). The chromosomal instability pathway in colon cancer. Gastroenterology 138: 2059–2072.
Polesskaya A, Cuvellier S, Naguibneva I, Duquet A, Moss EG, Harel-Bellan A . (2007). Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes Dev 21: 1125–1138.
Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN et al. (1992). APC mutations occur early during colorectal tumorigenesis. Nature 359: 235–237.
Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR et al. (1993). Association of the APC gene product with beta-catenin. Science 262: 1731–1734.
Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA et al. (2007). Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci U S A 104: 11400–11405.
Sikora K, Chan S, Evan G, Gabra H, Markham N, Stewart J et al. (1987). c-myc oncogene expression in colorectal cancer. Cancer 59: 1289–1295.
Snippert HJ, van Es JH, van den Born M, Begthel H, Stange DE, Barker N et al. (2009). Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine. Gastroenterology 136: 2187–2194 e1.
Stewart J, Evan G, Watson J, Sikora K . (1986). Detection of the c-myc oncogene product in colonic polyps and carcinomas. Br J Cancer 53: 1–6.
Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H et al. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753–3756.
Uchida H, Yamazaki K, Fukuma M, Yamada T, Hayashida T, Hasegawa H et al. (2010). Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer. Cancer Sci 101: 1731-1737.
Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917–1920.
Zhao Y, Deng C, Wang J, Xiao J, Gatalica Z, Recker RR et al. (2010). Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Breast Cancer Res Treat 127: 69–80.
Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, Bayazitov IT et al. (2009). Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457: 603–607.
Acknowledgements
This work was supported by R01-DK056645 (AR, CK and PM). Hauser Foundation, National Colon Cancer Research Alliance (EIF) and American Cancer Society Research Professorship (AR). Catrina King is a Pfizer Animal Health scholarship recipient, a doctoral candidate in Biomedical Graduate Studies, and a student of the School of Veterinary Medicine at the University of Pennsylvania. We thank Dr Joshua Mendell for gifts of LIN28B expression vectors, as well as Ben Rhoades and Mark Bowser for technical assistance. We also acknowledge help from the NIH/NIDDK P30-DK050306 Center for Molecular Studies in Digestive and Liver Diseases and its Molecular Biology and Cell Culture Core Facilities and NIH U01-DK085551. Louise Wang was supported by an NIH ARRA student fellowship through the NIH P30 DK050306.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
King, C., Wang, L., Winograd, R. et al. LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms. Oncogene 30, 4185–4193 (2011). https://doi.org/10.1038/onc.2011.131
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.131
Keywords
This article is cited by
-
Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA
Hereditas (2023)
-
A comprehensive review on RNA interference-mediated targeting of interleukins and its potential therapeutic implications in colon cancer
3 Biotech (2023)
-
RNA-binding protein complex LIN28/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7
Oncogene (2022)
-
LIN28B inhibition sensitizes cells to p53-restoring PPI therapy through unleashed translational suppression
Oncogenesis (2022)
-
The LIN28B/TGF-β/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinoma
Cancer Gene Therapy (2022)